Trigger 1: Diabetes Flashcards

1
Q

diabetes mellitus

A

hyperglycaemia due to insufficient insulin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Clinical def:

A

fasting blood glucose over 7mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

type 1 incidence vs T2

A

10% vs 90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Consequences of diabtes

A
  • Reduces life expectancy between:
    o 5 to 14 years in people with T1
    o 6 years for Y2
  • Contributes to kidney failure and CVD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Monogenic forms

A

Single gene defects causes diabetes (due to B-cell defect)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

types of monogenic diabetes

A
  • Neonatal

- Maturity onset diabetes of the young

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Neonatal gene defects

A
  • Most common mutations in KCNJ11 and ABCC8 (form subunits of kATP channel)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

(2) Maturity onset diabetes of the young (MODY) gene defect

A
  • 6 genes have been identified that account for 87% of UK MODY:
    i. HNF1A
    ii. HNF1B
    iii. Hnf4A
    iv. Glucokinase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Type 2 diabetes

A

Hyperglycaemia due to insufficient secretion. Combination of increased insulin resistance and beta-cell defects. Can have very high levels of insulin secretion, but due to insulin resistance glucose levels remain high.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

presentation of T2DM

A
Presentation of type 2 diabetes
	Long duration
	Older at diagnosis: 50s and 60s
	Overweight
	Strong family history
	Thirst, hunger, polyuria 
	Oral and vaginal thrush
	Tiredness, sleepiness , change of behaviour
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Treatment of type 2 diabetes

A
	Diet
	Exercise
	Drugs to improve insulin sensitivity
	Drugs to stimulate insulin secretion
	Drugs to promote glucose excretion via the kidneys
	Insulin injections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Drugs to stimulate insulin secretion

A
  • GLP-1 agonists

- Sulphonylureas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Drugs to promote glucose excretion via the kidneys

A
  • Gliflozins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Drugs to improve insulin sensitivity

A
  • Metformin

- Pioglitazone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Type 1 diabetes

A

Autoimmune destruction of insulin-producing beta cells of the pancreas. Due to a presence of autoantibodies and autoreactive T-cells directed against islet cells or their antigenic constituents e.g. Insulin, GAD65, IA-2.
 People with type 1 diabetes selectively lose the insulin-secreting B-cells from their islets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Possible reasons for destruction of B cells in T1DM

A
  • Vit D def
  • Virus?
  • environmental toxins
  • hygiene hypothesis
  • overt diabtes
17
Q

precipitating events

A

Cause (an event or situation, typically one that is undesirable) to happen suddenly, unexpectedly, or prematurely- in T1D occurs in older people

18
Q

Symptoms of T1DM

A
  • thirst
  • thinner
  • tired
  • toilet
19
Q

Characteristics of T1DM

A
  • Young age onset
  • Sudden onset
  • Thin
  • Immune-auto antibodies, T cells
  • Genetic- MHC class II and I, CTLA4
  • Family history
  • Insulin deficient
  • Ketoacidosis
20
Q

treatment of T1DM

A
  • Insulin replacement therapy- injections or pump
  • Regular blood glucose monitoring
  • Carbohydrate counting/exercise
  • Transplantation- islet or pancreas
21
Q

Testing for diabtes

A
  • HbA1c
  • FPG
  • OGTT
  • Random venous blood glucose
22
Q

HbA1c

A

 Measures % of glycated H in the blood
 Increased in more hyperglycaemic periods
 >6.5% for clinical diagnosis
 Advantage: doesn’t require fasting and representative of glycaemic control form the past 3 months

23
Q

Fasting blood glucose

24
Q

Random venous blood glucose

A

> 11.1mmol/l

25
testing for type 1
(1) Anti-GAD autoantibodies  Presence observed in 75% of T1 diabetes (2) Serum C-peptide  Marker for insulin production levels (3) Insulin autoantibodies  In around 50% T1 diabetes children, not commonly detected in adults
26
(1) Anti-GAD autoantibodies
 Presence observed in 75% of T1 diabetes
27
(2) Serum C-peptide
 Marker for insulin production levels
28
(3) Insulin autoantibodies
 In around 50% T1 diabetes children, not commonly detected in adults
29
Gliflozins
stimulate glucose excretion via the kidneys (SGLT2 inhibitors help the kidneys lower blood glucose levels.)
30
Metformin and Pioglitazone
enhances sensitivity to insulin
31
GLP-1 agonists and Sulphonylureas
stimulate insulin secretion